Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Refer & Earn
Arihant Plus App

Arihant Plus App

Bharat Immunological & Biological Corporation Ltd

Bharat Immunolog | 524663

Market Closed
₹9.00
+₹0.26 (+2.97%)
As on 22/11/26, 1:38 PM
Market Cap--- CR
Current Price₹---
High / Low₹--- / ---
PE Ratio---
Book Value₹---
Dividend Yield---
ROCE---
ROE0.00%
Face Value₹2.00
Current Vol.---
Average Vol.---
ISININE994B01014
PB Ratio---
Debt to Equity---
Net Profit Margin---
Operating Margin---

- Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹8.74₹8.5
₹9
Previous CloseToday's Open
₹7.11₹22.61
₹9
52W Low52W High
₹8.5Today's Open
₹8.74Previous Close
20,447Volume
₹7.1152W Low
₹22.6152W High

Ratios

📊

Consolidated data not available

Please try selecting a different data type

About Company

  • The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology
  • BIBCOL was incorporated in 1989
  • The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets
  • The company's manufacturing unit is located in Bulandshahr Dist
  • BIBCL installed a plant of 100 mln units
  • Commercial production of the OPV started from Jan'96
  • The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme
  • It has set up an R&D unit for the development of hepatitis B vaccine through transfer of technology from the US
  • In year 2006, the facility was up graded to meet the WHO cGMP & revised schedule M of Drugs & Cosmetics Act
  • In 2016, BIBCOL switched over to bOPV from tOPV

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSIN/A
SMA 20N/A
SMA 50N/A
SMA 100N/A
SMA 200N/A
SMA 10N/A
MACD_12_26_DaysN/A
EMA10DayN/A
EMA20DayN/A
EMA50DayN/A
MACD_12_26_9_DaysN/A
EMA100DayN/A
EMA200DayN/A

Pivot Points

Volume Analysis
📊

No Information Available

Volume Analysis data is not available at this time.

Growth Rate
📊

No Information Available

Growth Rate information is not available at this time.

All figures in ₹ Crores

📊

No Information Available

No profit & lossdata available

Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
29 Dec 2023
AGM
AGM
28 Nov 2023
30 Sept 2022
AGM
AGM
20 Sept 2022
30 Nov 2021
AGM
AGM
01 Nov 2021

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
9
0
1,885
4,52,299
37
5
30
0
19.78%
11,200
2,97,325
87
17
76
0
24.32%
4,699
1,78,727
82
10
44
1
11.09%
2,295
1,24,002
93
20
68
1
13.06%
1,195
1,19,207
26
4
18
0
9.82%
1,391
1,16,145
41
3
24
0
12.34%
1,415
1,14,312
37
3
26
0
9.92%
2,660
1,09,870
47
6
34
0
13.57%
1,795
1,03,298
25
3
17
0
10.41%
Showing 10 of 141 Results

Frequently Asked Questions

What is Share Price of Bharat Immunological & Biological Corporation Ltd?

The current share price of Bharat Immunological & Biological Corporation Ltd (Bharat Immunolog) is ₹9.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the 52-week high and low of Bharat Immunological & Biological Corporation Ltd?

Bharat Immunological & Biological Corporation Ltd has a 52-week high of ₹22.61 and a 52-week low of ₹7.11. This range shows the stock's price volatility over the past year.

What is the ROE of Bharat Immunological & Biological Corporation Ltd?

Bharat Immunological & Biological Corporation Ltd has a Return on Equity (ROE) of 0.00%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2